Posts Tagged ‘Pharmas’
Pharmaceutical companies have lost the right to block public comments on their company page walls. The privilege was previously granted exclusively to pharmaceutical companies who had been slow to set up company pages on the social media site.
Several companies (AstraZeneca, J&J, etc.) have already closed down pages, expressing concern about the extra resources that will be required to monitor activity.
Brilliant argumentation of 6 disruptive trends to industry, including Pharma.
- Information overload
- Limited access to interactive technologies
- Cloud computing
- Generation gap
- Social, social, social
- The Network society
Anyway, “Most companies still have an organisational structure designed for the 20th century: hierarchical, directive, silo-structured and sales-driven (aka Enterprise 1.0).
Especially in our ‘knowledge-intensive companies’ we need to mobilize the minds of our workforce in such way that we offer them freedom to do their jobs, give them access to information, provide them with a network that enables them to connect with peers and the likeminded and stimulate collaboration and co-creation (aka Enterprise 2.0).
Not only will such company create an environment that motivates people and retains talent, it also will lead to an increase in net income per employee.”
Van den Bos, René. Enterprise 2.0: part 2 – the world around us has changed, forever. In PharmaForum, Online. Posted on May 10, 2011.
A lot of critical things, according the Blue Reference blog…
GSK, Merck, Pfizer, Sanofi, Novartis, etc. have already adopted the Microsoft’s platform.
Many pharmaceutical companies are considering using SharePoint as the basis for the collaboration/outsourcing tool.
Blue reference offers specific add-ons which compensates some lacks of SharePoint, especially core-business capabilities needed in a scientific environment like pharmaceutical R&D.